α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(DOI: 10.21203/rs.3.rs-7375981/v1)
Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using Deep Docking
– Molecular Systems Biology
(2025)
(DOI: 10.1038/S44320-025-00159-5)
Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using Deep Docking
– Molecular Systems Biology
(2025)
(DOI: 10.1038/S44320-025-00159-5)
Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue
– Nat Biomed Eng
(2025)
1
(DOI: 10.1038/s41551-025-01496-4)
Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates.
– Communications chemistry
(2025)
8,
284
(DOI: 10.1038/s42004-025-01659-z)
Advances in Proximity-Assisted Bioconjugation
– Accounts of chemical research
(2025)
58,
2939
(DOI: 10.1021/acs.accounts.5c00368)
Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson’s Disease
(2025)
(DOI: 10.1101/2025.09.17.676873)
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay
– J Am Chem Soc
(2025)
147,
35942
(DOI: 10.1021/jacs.5c12812)
Tumor-Specific STING Agonist Synthesis via a Two-Component Prodrug System
– Nat Chem
(2025)
1
(DOI: 10.1038/s41557-025-01930-9)
Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson’s disease
(2025)
(DOI: 10.1101/2025.08.25.671921)
Rapid elongation drives the exceptionally fast aggregation of medin, the most common localized human amyloid
(2025)
(DOI: 10.21203/rs.3.rs-6476074/v1)
α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(DOI: 10.1101/2025.08.19.670819)
[2.2.1]Heterobicyclic Bromovinyl Sulfones for Thiol-Triggered Strategies in Linker Chemistry: Aza- vs Oxa-Norbornadienic Systems
– Bioconjugate Chemistry
(2025)
36,
2079
An unnatural base pair for the detection of epigenetic cytosine modifications in DNA
– Nat Chem
(2025)
1
(DOI: 10.1038/s41557-025-01925-6)
Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion Model
(2025)
(DOI: 10.1101/2025.08.16.670694)
Predicting Experimental Success in De Novo Binder Design: A Meta-Analysis of 3,766 Experimentally Characterised Binders
(2025)
(DOI: 10.1101/2025.08.14.670059)
Correction: Modifying recombinant purple acid phosphatase using computational design
– Eur Biophys J
(2025)
1
(DOI: 10.1007/s00249-025-01792-6)
Classification of Tauopathies from Human Brain Homogenates through Salt-Modulated Tau Amplification
(2025)
(DOI: 10.1101/2025.08.05.25331458)
A Charge-Driven Strategy for Covalent Modification and Modulation of Biomolecular Condensates
– J Am Chem Soc
(2025)
147,
28558
(DOI: 10.1021/jacs.5c06625)